Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7540)
All Articles published online
|
Publishing Process of This Article
|
Dec 12, 2018 (publication date) through Jan 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gurevich VV, Gurevich EV. Arrestin-mediated signaling: Is there a controversy? World J Biol Chem 2018; 9(3): 25-35 [PMID: 30595812 DOI: 10.4331/wjbc.v9.i3.25] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v9/i3/25.htm |
| Number | Citing Articles |
| 1 |
Mithu Baidya, Punita Kumari, Hemlata Dwivedi‐Agnihotri, Shubhi Pandey, Madhu Chaturvedi, Tomasz Maciej Stepniewski, Kouki Kawakami, Yubo Cao, Stéphane A Laporte, Jana Selent, Asuka Inoue, Arun K Shukla.
Key phosphorylation sites in
GPCR
s orchestrate the contribution of β‐Arrestin 1 in
ERK
1/2 activation
. EMBO reports 2020; 21(9) doi: 10.15252/embr.201949886
|
| 2 |
Peter Kolb, Terry Kenakin, Stephen P. H. Alexander, Marcel Bermudez, Laura M. Bohn, Christian S. Breinholt, Michel Bouvier, Stephen J. Hill, Evi Kostenis, Kirill A. Martemyanov, Rick R. Neubig, H. Ongun Onaran, Sudarshan Rajagopal, Bryan L. Roth, Jana Selent, Arun K. Shukla, Martha E. Sommer, David E. Gloriam. Community guidelines for GPCR ligand bias: IUPHAR review 32. British Journal of Pharmacology 2022; 179(14): 3651 doi: 10.1111/bph.15811
|
| 3 |
Selin Schamiloglu, Elinor Lewis, Caroline M. Keeshen, Anne C. Hergarden, Kevin J. Bender, Jennifer L. Whistler. Arrestin-3 Agonism at Dopamine D3 Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance. Biological Psychiatry 2023; 94(7): 531 doi: 10.1016/j.biopsych.2023.03.006
|
| 4 |
Shubhi Pandey, Xaria X. Li, Ashish Srivastava, Mithu Baidya, Punita Kumari, Hemlata Dwivedi, Madhu Chaturvedi, Eshan Ghosh, Trent M. Woodruff, Arun K. Shukla. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1. Journal of Biological Chemistry 2019; 294(24): 9416 doi: 10.1074/jbc.RA119.007485
|
| 5 |
Claes Dahlgren, André Holdfeldt, Simon Lind, Jonas Mårtensson, Michael Gabl, Lena Björkman, Martina Sundqvist, Huamei Forsman. Neutrophil Signaling That Challenges Dogmata of G Protein-Coupled Receptor Regulated Functions. ACS Pharmacology & Translational Science 2020; 3(2): 203 doi: 10.1021/acsptsci.0c00004
|
| 6 |
Edda Sofie Fabienne Matthees, Raphael Silvanus Haider, Carsten Hoffmann. β-arrestin–based biosensors: Tools to explore structural determinants of metabolic functions?. Current Opinion in Endocrine and Metabolic Research 2021; 16: 66 doi: 10.1016/j.coemr.2020.09.006
|
| 7 |
Bernd Nürnberg, Sandra Beer-Hammer, Ellen Reisinger, Veronika Leiss. Non-canonical G protein signaling. Pharmacology & Therapeutics 2024; 255: 108589 doi: 10.1016/j.pharmthera.2024.108589
|
| 8 |
Mohamed R. Ahmed, Chen Zheng, Jeffery L. Dunning, Mohamed S. Ahmed, Connie Ge, F. Sanders Pair, Vsevolod V. Gurevich, Eugenia V. Gurevich. Arrestin-3-assisted activation of JNK3 mediates dopaminergic behavioral sensitization. Cell Reports Medicine 2024; 5(7): 101623 doi: 10.1016/j.xcrm.2024.101623
|
| 9 |
Mithu Baidya, Punita Kumari, Hemlata Dwivedi-Agnihotri, Shubhi Pandey, Badr Sokrat, Silvia Sposini, Madhu Chaturvedi, Ashish Srivastava, Debarati Roy, Aylin C. Hanyaloglu, Michel Bouvier, Arun K. Shukla. Genetically encoded intrabody sensors report the interaction and trafficking of β-arrestin 1 upon activation of G-protein–coupled receptors. Journal of Biological Chemistry 2020; 295(30): 10153 doi: 10.1074/jbc.RA120.013470
|
| 10 |
Céline Delaitre, Michel Boisbrun, Sandra Lecat, François Dupuis. Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes. International Journal of Molecular Sciences 2021; 22(13): 6738 doi: 10.3390/ijms22136738
|
| 11 |
David J. Marcus, Michael R. Bruchas, Gunnar Schulte. Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling. Pharmacological Reviews 2023; 75(6): 1119 doi: 10.1124/pharmrev.122.000584
|
| 12 |
Ilya S. Senatorov, Ameneh Cheshmehkani, Rebecca N. Burns, Kirti Singh, Nader H. Moniri. Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates β-Arrestin Recruitment and Signaling to ERK1/2. Molecular Pharmacology 2020; 97(5): 304 doi: 10.1124/mol.119.117697
|
| 13 |
Hemlata Dwivedi-Agnihotri, Madhu Chaturvedi, Mithu Baidya, Tomasz Maciej Stepniewski, Shubhi Pandey, Jagannath Maharana, Ashish Srivastava, Natarin Caengprasath, Aylin C. Hanyaloglu, Jana Selent, Arun K. Shukla. Distinct phosphorylation sites in a prototypical GPCR differently orchestrate β-arrestin interaction, trafficking, and signaling. Science Advances 2020; 6(37) doi: 10.1126/sciadv.abb8368
|
| 14 |
|
| 15 |
Vsevolod V. Gurevich. Arrestins: A Small Family of Multi-Functional Proteins. International Journal of Molecular Sciences 2024; 25(11): 6284 doi: 10.3390/ijms25116284
|
| 16 |
Yonghoon Kwon, Sohum Mehta, Mary Clark, Geneva Walters, Yanghao Zhong, Ha Neul Lee, Roger K. Sunahara, Jin Zhang. Non-canonical β-adrenergic activation of ERK at endosomes. Nature 2022; 611(7934): 173 doi: 10.1038/s41586-022-05343-3
|
| 17 |
Vsevolod V. Gurevich, Eugenia V. Gurevich. Biased GPCR signaling: Possible mechanisms and inherent limitations. Pharmacology & Therapeutics 2020; 211: 107540 doi: 10.1016/j.pharmthera.2020.107540
|
| 18 |
Paula Santos-Otte, Hanne Leysen, Jaana van Gastel, Jhana O. Hendrickx, Bronwen Martin, Stuart Maudsley. G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence. Computational and Structural Biotechnology Journal 2019; 17: 1265 doi: 10.1016/j.csbj.2019.08.005
|
| 19 |
Ali I. Kaya, Nicole A. Perry, Vsevolod V. Gurevich, T. M. Iverson. Phosphorylation barcode-dependent signal bias of the dopamine D1 receptor. Proceedings of the National Academy of Sciences 2020; 117(25): 14139 doi: 10.1073/pnas.1918736117
|
| 20 |
Enezi Khalid, John P. Chang. β-Arrestin-dependent signaling in GnRH control of hormone secretion from goldfish gonadotrophs and somatotrophs. General and Comparative Endocrinology 2020; 287: 113340 doi: 10.1016/j.ygcen.2019.113340
|
| 21 |
Mohammad Seyedabadi, Mehdi Gharghabi, Eugenia V. Gurevich, Vsevolod V. Gurevich. Receptor-Arrestin Interactions: The GPCR Perspective. Biomolecules 2021; 11(2): 218 doi: 10.3390/biom11020218
|
| 22 |
Gábor Turu, András Balla, László Hunyady. The Role of β-Arrestin Proteins in Organization of Signaling and Regulation of the AT1 Angiotensin Receptor. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00519
|
| 23 |
Laura E. Kilpatrick, Stephen J. Hill. Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies. Current Opinion in Endocrine and Metabolic Research 2021; 16: 102 doi: 10.1016/j.coemr.2020.10.003
|
| 24 |
Ana Sofia Brito, Benjamin Neuhäuser, René Wintjens, Anna Maria Marini, Mélanie Boeckstaens, Joseph Heitman. Yeast filamentation signaling is connected to a specific substrate translocation mechanism of the Mep2 transceptor. PLOS Genetics 2020; 16(2): e1008634 doi: 10.1371/journal.pgen.1008634
|
| 25 |
Amy E. Moritz, R. Benjamin Free, Warren S. Weiner, Emmanuel O. Akano, Disha Gandhi, Ara Abramyan, Thomas M. Keck, Marc Ferrer, Xin Hu, Noel Southall, Joseph Steiner, Jeffrey Aubé, Lei Shi, Kevin J. Frankowski, David R. Sibley. Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist. Journal of Medicinal Chemistry 2020; 63(10): 5526 doi: 10.1021/acs.jmedchem.0c00424
|
| 26 |
Sara Gómez-Melero, Javier Caballero-Villarraso. CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases. Antibodies 2023; 12(2): 30 doi: 10.3390/antib12020030
|
| 27 |
Tobias Benkel, Mirjam Zimmermann, Julian Zeiner, Sergi Bravo, Nicole Merten, Victor Jun Yu Lim, Edda Sofie Fabienne Matthees, Julia Drube, Elke Miess-Tanneberg, Daniela Malan, Martyna Szpakowska, Stefania Monteleone, Jak Grimes, Zsombor Koszegi, Yann Lanoiselée, Shannon O’Brien, Nikoleta Pavlaki, Nadine Dobberstein, Asuka Inoue, Viacheslav Nikolaev, Davide Calebiro, Andy Chevigné, Philipp Sasse, Stefan Schulz, Carsten Hoffmann, Peter Kolb, Maria Waldhoer, Katharina Simon, Jesus Gomeza, Evi Kostenis. How Carvedilol activates β2-adrenoceptors. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-34765-w
|
| 28 |
Patrick Grudzien, Henry Neufeld, Mbasogo Ebe Eyenga, Vadim Gaponenko. Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1184014
|
| 29 |
Valeria Burghi, Justine S. Paradis, Adam Officer, Sendi Rafael Adame-Garcia, Xingyu Wu, Edda S.F. Matthees, Benjamin Barsi-Rhyne, Dana J. Ramms, Lauren Clubb, Monica Acosta, Pablo Tamayo, Michel Bouvier, Asuka Inoue, Mark von Zastrow, Carsten Hoffmann, J. Silvio Gutkind. Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor. Journal of Biological Chemistry 2023; 299(11): 105293 doi: 10.1016/j.jbc.2023.105293
|
| 30 |
Yvonne Giesecke, Vahid Asimi, Valentina Stulberg, Gunnar Kleinau, Patrick Scheerer, Beate Koksch, Carsten Grötzinger. Is the Neuropeptide PEN a Ligand of GPR83?. International Journal of Molecular Sciences 2023; 24(20): 15117 doi: 10.3390/ijms242015117
|
| 31 |
Raphael S. Haider, Mona Reichel, Edda S. F. Matthees, Carsten Hoffmann. Conformational flexibility of β‐arrestins – How these scaffolding proteins guide and transform the functionality of GPCRs. BioEssays 2023; 45(8) doi: 10.1002/bies.202300053
|
| 32 |
Raphael S. Haider, Edda S. F. Matthees, Julia Drube, Mona Reichel, Ulrike Zabel, Asuka Inoue, Andy Chevigné, Cornelius Krasel, Xavier Deupi, Carsten Hoffmann. β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR in living cells. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-33307-8
|
| 33 |
Anna Pietraszewska-Bogiel, Linda Joosen, Anna O. Chertkova, Joachim Goedhart. Not So Dry After All: DRY Mutants of the AT1A Receptor and H1 Receptor Can Induce G-Protein-Dependent Signaling. ACS Omega 2020; 5(6): 2648 doi: 10.1021/acsomega.9b03146
|
| 34 |
Tao Che, Bryan L. Roth. Molecular basis of opioid receptor signaling. Cell 2023; 186(24): 5203 doi: 10.1016/j.cell.2023.10.029
|
| 35 |
Zdenka Drastichova, Radka Trubacova, Jiri Novotny. β-Arrestin2 Is Critically Involved in the Differential Regulation of Phosphosignaling Pathways by Thyrotropin-Releasing Hormone and Taltirelin. Cells 2022; 11(9): 1473 doi: 10.3390/cells11091473
|
| 36 |
Sara Gómez-Melero, Fé Isabel García-Maceira, Tania García-Maceira, Verónica Luna-Guerrero, Gracia Montero-Peñalvo, Isaac Túnez-Fiñana, Elier Paz-Rojas. Amino terminal recognition by a CCR6 chemokine receptor antibody blocks CCL20 signaling and IL-17 expression via β-arrestin. BMC Biotechnology 2021; 21(1) doi: 10.1186/s12896-021-00699-2
|
| 37 |
Alexander Sebastian Hauser. Comprehensive Pharmacology. 2022; : 191 doi: 10.1016/B978-0-12-820472-6.00100-6
|